Companies / Rani Therapeutics Holdings, Inc. / Activity
Activity — Rani Therapeutics Holdings, Inc.
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common stock | $112.7K | +153K | 153,331 0.12% of shares | low |
| Q4 2025 as of | Farallon Capital Management LLC 13F manager | New | Common stock | $105.3K | +78K | 78,000 0.06% of shares | low |
| Q4 2025 as of | Sanctuary Advisors, LLC 13F manager | New | Common stock | $16.2K | +12K | 12,014 <0.01% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | New | Common stock | $10.9K | +8K | 8,096 <0.01% of shares | low |
| Q1 2026 as of | Bank of New York Mellon Corp/The 13F manager | New | Common stock | $10.2K | +14K | 13,879 0.01% of shares | low |
| Q1 2026 as of | Zurcher Kantonalbank (Zurich Cantonalbank) 13F manager | New | Common stock | $7.7K | +11K | 10,502 <0.01% of shares | low |
| Q1 2026 as of | Federated Hermes Inc 13F manager | New | Common stock | $587 | +799 | 799 <0.01% of shares | low |
| Q1 2024 as of | Barclays PLC 13F manager | New | Common stock | $121 | +39 | 39 <0.01% of shares | low |
| Q1 2026 as of | Gsa Capital Partners LLP 13F manager | New | Common stock | $71 | +97K | 96,998 0.08% of shares | low |